West Pharmaceutical Services and Swissfillon AG have commenced discussions that are intended to lead to a non-exclusive global collaboration to provide fill-finish capabilities to customersusing West’s proprietary SmartDose drug delivery platform for complex molecules.
Through the collaboration, it is anticipated that West will be able to deliver an integrated solution with filled Daikyo Crystal Zenith cartridges for the SmartDose wearable injector, which is expected to accelerate clinical development and enable customers to bring their innovative injectable drugs to market quickly. This new collaboration is expected to offer customers a robust clinical fill-finish capability later this year.
“We are very pleased to partner with Swissfillon delivery solution supporting our customers’ journey from molecule to market. It combines Swissfillon’sfill-finish expertise with West’s proprietary drug delivery technology to deliver a streamlined solution that meets the unique needs of pharmaceutical manufacturers around the world,” said Karen Flynn, SVP & Chief Commercial Officer, West.
“We are excited to work with West to bring our fill-finish capabilities to West’s SmartDose platformoffering,” said Daniel Kehl, Chief Executive Officer, Swissfillon AG. “We look forward to partneringtogether to support pharmaceutical and biotech customers to deliver innovative combination drugproducts to patients.”
Wearable drug delivery systems offer physicians having patients with chronic health conditions who require daily administration a reliable, convenient and easy to use method for home-based drug administration.
West’s SmartDose drug delivery platform enables patients to self-administer medication in accordance with their prescribed treatment. West developed the SmartDose platform with extensive human factors testing and analysis to understand the interaction between the patient and the delivery system. The SmartDose platform adheres to the patient’s body, usually on the abdomen, so patients can be hands- free during administration. The SmartDose platform is an integrated solution for the containment and delivery of injectable medications featuring a silicone-free Daikyo Crystal Zenith cartridge and a Flurotec barrier film coated piston primary containment system.
Clinical fill-finish services are part of West’s new Integrated Solutions Program. The Program offers customers the opportunity to Simplify the Journey from molecule to market with containment and delivery solutions for combination products; analytical testing services; regulatory support; and device manufacturing, assembly and drug handling designed for any stage of the drug development lifecycle.